TENON MEDICAL INC (TNON) Stock Income Statement
NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.28M | 3.28M | 2.93M | 690.00K | 160.00K | |||
| Minority Interest Expense | N/A | N/A | N/A | 0.00 | 30.00K | |||
| Cost Of Goods | 1.72M | 1.57M | 1.69M | 1.33M | 50.00K | |||
| Gross Profit | 1.56M | 1.71M | 1.24M | -640.00K | 110.00K | |||
| Operating Expenses | 15.50M | 15.48M | 16.97M | 18.09M | 6.57M | |||
| Research and Development | 2.63M | 2.60M | 3.16M | 2.83M | 1.72M | |||
| Selling, General, and Administrative Expenses | 12.88M | 12.87M | 13.80M | 15.26M | 4.85M | |||
| Operating Income | -13.94M | -13.77M | -15.73M | -18.73M | -6.46M | |||
| Interest Income/Expense | 217.00K | 149.00K | 146.00K | -170.00K | -620.00K | |||
| Other Income/Expense | 7.00K | -56.00K | 0.00 | -20.00K | 0.00 | |||
| Income Before Taxes | -13.71M | -13.67M | -15.58M | -18.92M | -7.08M | |||
| Net Income | -13.71M | -13.67M | -15.58M | -18.92M | -7.05M | |||
| EBITDA | -13.28M | -13.11M | -15.30M | -18.65M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.78 | -11.26 | -68.71 | -23.65 | -6.29 | |||
| Non GAAP EPS | -15.34 | -24.33 | -77.92 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 47.62% | 52.21% | 42.38% | -92.75% | 68.75% | |||
| Profit Margin | -417.57% | -417.24% | -532.14% | -2742.03% | -4406.25% | |||
| Operating Profit Margin | -424.39% | -420.08% | -537.12% | -2714.49% | -4037.50% | |||
All data in USD